CT结肠成像在结直肠癌筛查中的现状
本文综述CT结肠成像(CTC)作为结直肠癌筛查手段的现状。CTC对临床有意义息肉具有与结肠镜相当的敏感性,安全性良好。长期观察性队列研究证实了既定息肉大小阈值在阳性率和筛查监测间隔方面的安全性。
要点
- CTC检出临床有意义息肉的敏感性等同于结肠镜
- 高质量成像需肠道清洁、粪便标记和结肠充分扩张
- CTC可选择性切除大息肉、监测小息肉并忽略微小病变
核心结论
- CTC是经过验证的结直肠癌筛查和预防手段,对临床有意义息肉的敏感性与结肠镜相当,安全性记录良好。
- CTC和结肠镜是唯一足够准确用于一级预防的检查方法,而粪便检查和血液检查仅限在较短筛查窗口内检测癌症。
- 尽管证据支持CTC为理想筛查手段,但因放射科实践和医生支持方面的障碍导致其利用率持续偏低。
研究设计与样本
- 本文为综述类文献,检索范围与纳入文献未在原文中具体列出。
- 文中纳入长期观察性CTC队列研究以验证息肉大小阈值的筛查和监测间隔安全性。
- 2025年起美国Medicare受益人筛查性CTC获得覆盖,与其他CRC筛查检查处于同等地位。
关键影像表现/征象
- CTC影像需重点识别扁平无蒂锯齿状病变(SSLs),对高质量成像和判读具有挑战性。
- 大型SSLs和腺瘤性息肉是最相关的良性癌前病变,是一级预防策略的主要靶点。
- CTC可对息肉进行风险分层,大息肉建议切除,小息肉进行监测,微小病变可忽略。
诊断标准与关键数值
- CTC与结肠镜对临床有意义息肉的敏感性相当,具体数值原文未给出。
- 长期观察性CTC队列研究确认了既定息肉大小阈值在阳性率和筛查监测间隔方面是安全的。
- CTC比单纯结肠镜普遍息肉切除策略能更有效识别进展期肿瘤,减少假性疾病切除和结肠穿孔风险。
临床应用与阅片要点
- 阅片时需重点关注扁平无蒂锯齿状病变的检出,这对检查技术和判读要求较高。
- 报告应根据息肉大小进行风险分层,指导临床对大息肉选择性切除、小息肉监测。
- 日常实践中需克服CTC利用不足的障碍,推动机会性筛查的开展。
局限性
- CTC因放射科实践和医生支持方面的障碍而面临广泛且不断恶化的利用不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
CT colonography (CTC) is a validated screening test for detection and prevention of colorectal cancer (CRC). In the United States, screening CTC has been covered for Medicare beneficiaries since 2025, elevating it to equal status with other reimbursed CRC screening tests and ending a 15-year policy stalemate. Screening CTC is a highly accurate examination with an immaculate safety record and equivalent sensitivity to colonoscopy for clinically significant polyps. Long-term observational CTC cohorts confirm safety for established polyp size thresholds in terms of test positivity and screening and surveillance intervals. Excellent technique with cathartic bowel preparation, stool tagging, and colonic distention is necessary for high-quality imaging and interpretation, particularly in detection of flat sessile serrated lesions (SSLs). Large SSLs and adenomatous polyps are the most relevant benign precursor lesions to CRC and are the main target of a primary prevention screening strategy. Only CTC and colonoscopy are sufficiently accurate for primary prevention, whereas stool-based and recently approved blood-based tests are limited to detection of cancer in a shorter screening window. CTC allows for selective polypectomy by risk-stratifying large polyps for removal, surveilling small polyps, and ignoring diminutive lesions. CTC is more efficient at identifying advanced neoplasia compared with a universal polypectomy strategy of colonoscopy only, which removes more pseudodisease and incurs excess risk of colonic perforation without benefit. Despite abundant evidence supporting CTC as an ideal screening test, it suffers from widespread and worsening underutilization due to barriers affecting radiology practice and physician support. Opportunistic screening and national trends in the CRC screening landscape will impact future uptake of CTC.
引用
- Taya, Pickhardt, Lee, et al. CT Colonography: Where Are We with Colorectal Cancer Screening? Radiographics. 2026. PMID: 42821450. doi:10.1148/rg.260016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。